Skip to main content
. 2022 Mar 9;36(2):429–440. doi: 10.1111/jvim.16380

TABLE 3.

Patient demographics

Characteristic Total population, n (%) Survivors, n (%) Non‐survivors, n (%)
Sex
Female 4 (3.5) 1 (2.1) 2 (3.5)
Female spayed 36 (31.9) 16 (34.0) 18 (31.6)
Male 12 (10.6) 3 (6.4) 7 (12.3)
Male neutered 61 (54.0) 27 (57.4) 30 (52.6)
Breed group
Herding 19 (16.8) 9 (19.1) 9 (15.8)
Hound 7 (6.2) 4 (8.5) 2 (3.5)
Mix 25 (22.1) 9 (19.1) 13 (22.8)
Non‐sporting 3 (2.7) 1 (2.1) 2 (3.5)
Other 2 (1.8) 0 (0) 2 (3.5)
Sporting 33 (29.2) 16 (34.0) 16 (28.1)
Terrier 7 (6.2) 4 (8.5) 3 (5.3)
Toy 7 (6.2) 1 (2.1) 3 (5.3)
Working 10 (8.9) 3 (6.4) 7 (12.3)
Age category
Less than 3 years 16 (14.2) 7 (14.8) 8 (14.0)
3 to <6 years 20 (17.7) 9 (19.1) 9 (18.8)
6 to <9 years 29 (25.7) 9 (19.1) 19 (33.3)
9 to <12 years 29 (25.7) 13 (27.7) 14 (24.6)
12 years and older 19 (16.8) 9 (19.1) 7 (12.3)
Weight category
<10 kg 14 (12.7) 5 (10.6) 5 (9.1)
10 to <20 kg 7 (6.4) 2 (4.3) 5 (9.1)
20 to <30 kg 32 (29.1) 18 (38.3) 14 (25.5)
30 to <40 kg 39 (35.5) 16 (34.0) 22 (40.0)
40 kg and above 18 (16.4) 6 (12.8) 9 (16.4)
Preexisting conditions
Diabetes mellitus 2 (1.8) 2 (4.3) 0 (0)
Surgical implants 13 (11.5) 5 (10.6) 6 (10.5)
Neoplasia 11 (9.7) 6 (12.8) 4 (7.0)
Immunosuppression 27 (23.9) 14 (29.8) 12 (21.1)
Antibiotics in past 30 days 80 (80.8) 34 (72.3) 41 (71.9)
Chronic kidney disease 21 (18.6) 9 (19.2) 8 (14.0)